Proponents of drug price regulation argue that drug makers raise prices to benefit the value of their stock and invest little of their profits in the development and research of new drugs. Opponents of regulation argue that consumers rely on drug companies to develop new drugs and limiting prices will prevent new lifesaving drugs from being developed. Brazil is ranked top of the pharmaceutical markets in Latin America and third in North America, with a market value of $25.60bn in 2011.
77% Yes |
23% No |
69% Yes |
16% No |
5% Yes, and we should socialize medicine and healthcare |
3% No, limiting drug prices would also limit the investment in research and development into new life-saving drugs |
3% Yes, and the government should regulate the price of all prescription drugs |
2% No, but shorten the lifespan of drug patents |
2% No, and the government should never regulate prices of private businesses |
See how support for each position on “Drug Price Regulation” has changed over time for 139k Brazil voters.
Loading data...
Loading chart...
See how importance of “Drug Price Regulation” has changed over time for 139k Brazil voters.
Loading data...
Loading chart...
Unique answers from Brazil users whose views extended beyond the provided choices.
@99YHSG41yr1Y
Donald trump an drug use pan is different of going formed as government is not yet over
Explore other topics that are important to Brazil voters.
@ISIDEWITH6mos6MO
Proponents argue that this strategy would bolster national security by minimizing the risk of potential terrorists entering the country. Enhanced screening processes, once implemented, would provide a more thorough assessment of applicants, reducing the likelihood of malicious actors gaining entry.…
@ISIDEWITH2wks2W
In 2024 global leaders including Joe Biden, Rishi Sunak and Emmanuel Macron publicly questioned the leadership of Israeli Prime Minister Benjamin Netanyahu. Their criticisms came after the Gaza War reached a stalemate in March 2024 as Israel was planning an invasion of the Gaza City of Rafah. Western…